How Does Simparica Trio Kill Ticks on Your Dog?

Simparica Trio kills ticks through its active ingredient sarolaner, a compound that circulates in your dog’s bloodstream and poisons ticks when they bite and begin feeding. Sarolaner belongs to the isoxazoline class of parasiticides, which shut down a critical part of the tick’s nervous system. The process is surprisingly straightforward: the tick attaches, takes a blood meal laced with sarolaner, and within hours loses control of its muscles and dies.

How Sarolaner Gets to the Tick

Simparica Trio is a flavored chewable tablet that your dog swallows. Once in the digestive tract, sarolaner is absorbed into the bloodstream and distributed throughout your dog’s body, including the skin and subcutaneous tissue. Unlike topical treatments that sit on the skin surface or coat the fur, sarolaner works from the inside out. This means the drug doesn’t wash off in rain or baths, and you don’t have to worry about uneven application or greasy residue.

The trade-off is that a tick must actually bite your dog and start feeding to encounter the drug. Sarolaner doesn’t repel ticks or prevent them from climbing aboard. A tick will latch on, insert its mouthparts, and begin drawing blood just as it would on an untreated dog. The difference is that the blood it ingests contains a lethal dose of sarolaner. This is an important distinction, because it means you can find live ticks on a treated dog, especially in the first hours after attachment, and that doesn’t mean the product has failed.

What Happens Inside the Tick’s Nervous System

Sarolaner targets a specific type of receptor in the tick’s nervous system called the GABA-gated chloride channel. In a healthy tick, these channels help regulate nerve signaling. When nerve cells fire, GABA (a chemical messenger) opens these channels to let chloride ions flow in, which calms the nerve back down. It’s the tick’s natural braking system for neural activity.

Sarolaner jams that braking system. It inhibits GABA-elicited currents at these chloride channels, which means the tick’s nerves can no longer regulate themselves properly.1PubMed. Discovery of sarolaner: A novel, orally administered, broad-spectrum, isoxazoline ectoparasiticide for dogs The result is uncontrolled nerve firing, which leads to hyperexcitation, paralysis, and death. If you’ve ever seen a tick on a treated dog that’s still attached but barely moving or twitching its legs, that’s sarolaner at work. The tick’s muscles have lost coordination, and death follows.

One detail worth knowing: sarolaner works on both the normal (“susceptible”) and the mutated (“resistant”) forms of these GABA channels. Some insect populations have developed a mutation known as RDL (resistance-to-dieldrin) that makes them harder to kill with older pesticides. Electrophysiology studies have shown that sarolaner inhibits both versions with similar potency, which means ticks carrying this common resistance mutation are still vulnerable.1PubMed. Discovery of sarolaner: A novel, orally administered, broad-spectrum, isoxazoline ectoparasiticide for dogs

How Fast Does It Kill Ticks?

Speed matters with ticks because the longer they feed, the higher the chance they transmit pathogens. Studies measuring Simparica Trio’s speed of kill against black-legged ticks (the species that carries Lyme disease) found that a single dose reduced live tick counts by about two-thirds within eight hours and by over 98% within twelve hours of treatment.2PubMed Central. Evaluation of the speed of kill of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio) against induced infestations of Ixodes scapularis on dogs By 24 hours, efficacy consistently exceeded 94% and held at that level for at least four weeks.

Against European castor bean ticks, the numbers look similar: about 96% of live ticks were eliminated within 24 hours of treatment for an existing infestation, and efficacy stayed above 90% at 24 hours for over five weeks after a single dose.3PubMed. Evaluation of the speed-of-kill of Simparica Trio® against Ixodes ricinus in dogs The twelve-hour mark was less consistent against this species, with significant tick-count reductions during the first two weeks but not always hitting the 90% threshold at that early timepoint.

These numbers are for ticks already on the dog at the time of dosing. For new ticks that climb on later in the month, the story is broadly similar in the first couple of weeks. Against black-legged ticks, reinfestations were reduced by over 94% at 24 hours through at least four weeks.2PubMed Central. Evaluation of the speed of kill of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio) against induced infestations of Ixodes scapularis on dogs But as I’ll get into below, the speed of kill against certain tick species can start to slip later in the dosing interval.

Which Tick Species Does It Cover?

Not all ticks are the same, and different species can respond differently to treatment. Simparica Trio has been tested against the major tick species that affect dogs in the United States and beyond. In controlled studies against five common US species, a single dose delivered the following results within 48 hours:

The lone star tick is notably harder to kill quickly than the others, which is why its label claim uses the 72-hour window instead of 48 hours. Sarolaner alone (outside of the Trio combination) showed similarly strong results against these five species, with at least 99.6% efficacy against existing infestations within 48 hours and at least 96.9% against reinfestations for 35 days.5PubMed. Efficacy of a novel oral formulation of sarolaner (Simparica™) against five common tick species infesting dogs in the United States

More recently, Simparica Trio was also tested against the Asian longhorned tick, an invasive species that has established itself in parts of North America. It cleared about 99% of an existing infestation and maintained over 98% efficacy against reinfestations for at least 35 days.6Parasites & Vectors. Treatment and control of Haemaphysalis longicornis infestations on dogs using a formulation of sarolaner, moxidectin and pyrantel (Simparica Trio®)

Does Killing Ticks Fast Enough Prevent Disease Transmission?

This is the question that matters most to many dog owners. Ticks don’t just cause irritation; they transmit serious diseases like Lyme disease, anaplasmosis, ehrlichiosis, and Rocky Mountain spotted fever. Most of these pathogens require a period of sustained feeding before they move from the tick’s gut into the dog’s body. For Lyme disease in particular, the bacterium Borrelia burgdorferi typically needs the tick to feed for around 24 to 48 hours before transmission occurs.

A study specifically designed to test whether Simparica Trio prevents Lyme disease transmission found that it does. Both Simparica and Simparica Trio at their minimum label doses prevented B. burgdorferi infection as a direct result of killing the black-legged tick vectors before they could transmit the pathogen.7PubMed Central. Efficacy of Simparica and Simparica TRIO for the prevention of Borrelia burgdorferi by Ixodes scapularis Given the speed-of-kill data showing the vast majority of black-legged ticks dead within 12 to 24 hours, this result makes sense: the ticks die before they feed long enough to pass the bacterium along.

For other tick-borne diseases, there is less published data specifically using Simparica Trio in transmission-blocking studies. But the principle is the same. A product that kills ticks within hours of attachment interrupts the feeding window most pathogens require. Whether that window is met depends on the specific pathogen, the tick species, and where you are in the dosing month.

Why You Might Still See Ticks on Your Treated Dog

One of the most common concerns dog owners have is spotting a tick on their dog after giving Simparica Trio. This can feel alarming, but it doesn’t mean the product isn’t working. Isoxazolines kill ticks after they attach and begin feeding. A tick has to bite and ingest the treated blood before the drug takes effect. During that window, you can absolutely find a live tick on your dog.

You might also find ticks that are dead or dying but still physically attached. A tick embeds its mouthparts deep into the skin and cements them in place with a kind of biological glue. Even after the tick dies from sarolaner exposure, the body can remain stuck to the dog until the cement breaks down or you manually remove it. A dead tick that’s still attached is actually a sign the product did its job. If you’re unsure whether a tick is alive, look for leg movement. A dead or moribund tick’s legs will be curled inward and unresponsive.

Why It’s Toxic to Ticks but Not to Your Dog

Both ticks and mammals have GABA receptors, so a reasonable question is why sarolaner doesn’t poison your dog the same way it poisons the tick. The answer lies in how different the invertebrate and mammalian versions of these receptors are at the molecular level.

Isoxazolines were specifically designed to have a much stronger affinity for invertebrate GABA-gated chloride channels than for mammalian ones. Recent laboratory work comparing how different isoxazolines affect human and canine GABA receptors found that sarolaner’s IC50 values on canine receptors ranged from about 10 to 22 micromolar, and on human receptors from about 8 to above 30 micromolar. In practical terms, the concentrations needed to significantly block mammalian GABA receptors are vastly higher than the blood levels a treated dog actually reaches.8PubMed Central. Comparative analysis of isoxazoline activity on human and canine GABA receptors expressed in Xenopus oocytes Meanwhile, the drug concentrations in a dog’s blood after a normal dose are more than enough to overwhelm the much more sensitive insect-type GABA channels.

That same study found that among the isoxazolines tested, sarolaner and afoxolaner had generally higher IC50 values on mammalian receptors than fluralaner, meaning they needed higher concentrations to affect mammalian nerve signaling. Lotilaner showed the least effect on mammalian receptors of all.8PubMed Central. Comparative analysis of isoxazoline activity on human and canine GABA receptors expressed in Xenopus oocytes All of these drugs are considered safe for dogs at labeled doses, but the selectivity margin varies between compounds.

One population of dogs that sometimes gets flagged for extra caution is breeds carrying the MDR1 gene mutation (commonly collies and related herding breeds). This mutation affects a protein that helps keep certain drugs out of the brain. The concern is that drugs like moxidectin, which is also in Simparica Trio, could accumulate in the brain at higher-than-normal levels. Studies on a related isoxazoline-plus-macrocyclic-lactone combination in MDR1-deficient collies have shown a good safety profile, though the macrocyclic component (milbemycin oxime in that case) did produce mild, transient neurological signs in some dogs.9PubMed Central. Safety of oral afoxolaner formulated with or without milbemycin oxime in homozygous MDR1-deficient collie dogs If your dog has the MDR1 mutation or you’re unsure, it’s worth discussing with your vet.

How Performance Shifts Later in the Dosing Month

Simparica Trio is dosed monthly, and the drug concentration in your dog’s blood gradually declines over those 30-odd days. For most tick species, sarolaner maintains strong efficacy through the full month. But the speed at which it kills ticks can slow down toward the end of the dosing interval, particularly against the lone star tick.

A comparative study pitting sarolaner against lotilaner and afoxolaner on lone star tick infestations showed this clearly. On day zero (the day of dosing), sarolaner’s 24-hour efficacy against an existing infestation was about 74%, which was significantly lower than lotilaner and afoxolaner at that same timepoint. By day 21 after treatment, sarolaner’s 24-hour efficacy against a new infestation dropped to roughly 14%. By day 28, it was under 5% at the 24-hour mark, though it climbed back above 97% by 72 hours.10Parasites & Vectors. Comparative speed of kill provided by lotilaner (Credelio™), sarolaner (Simparica Trio™), and afoxolaner (NexGard™) to control Amblyomma americanum infestations on dogs

To be fair, afoxolaner performed similarly poorly against lone star ticks at these later timepoints. Only lotilaner maintained high 24-hour efficacy through day 28.10Parasites & Vectors. Comparative speed of kill provided by lotilaner (Credelio™), sarolaner (Simparica Trio™), and afoxolaner (NexGard™) to control Amblyomma americanum infestations on dogs The lone star tick is simply a tougher target for this drug class late in the cycle. This doesn’t mean Simparica Trio stops working; it means the ticks take longer to die, and that delay could matter for disease transmission. If your dog spends a lot of time in lone-star-tick habitat (much of the southeastern and eastern United States), staying strictly on schedule with monthly dosing is especially important.

How Oral Isoxazolines Compare to Topical Tick Products

Topical products and tick collars work by a fundamentally different principle. Many of them release active ingredients across the skin surface, creating a chemical barrier that can repel or kill ticks on contact, sometimes before they even bite. The advantage is that some topical approaches kill faster in the first few hours because the tick doesn’t need to feed to encounter the drug. A study comparing an imidacloprid/flumethrin collar against oral fluralaner found the collar achieved 94 to 100% efficacy against two tick species within six hours, while the oral product ranged from just 4 to 69% efficacy in that same early window.11PubMed Central. Comparative Efficacy of an Imidacloprid/Flumethrin Collar (Seresto®) and an Oral Fluralaner Chewable Tablet (Bravecto®) against Tick (Dermacentor variabilis and Amblyomma americanum) Infestations on Dogs: a Randomised Controlled Trial

The trade-offs cut the other way, though. Topical products can be washed off, rubbed off on furniture, or applied unevenly. Collars can be lost or chewed. Oral products provide consistent whole-body coverage regardless of bathing, swimming, or coat type. For most dog owners, the convenience and reliability of oral dosing outweigh the slightly slower initial kill speed, but if you’re in an extremely high-tick environment and worried about the attachment window, the comparison is worth understanding.

What Happens to Sarolaner After It Leaves Your Dog

A growing area of research looks at what happens when isoxazolines leave a treated pet’s body through feces. A recent study measured fecal elimination half-lives for four isoxazolines in dogs and found that sarolaner had the shortest half-life of the group, at about 17 days, compared to roughly 23 days for fluralaner, 25 for lotilaner, and 20 for afoxolaner.12PubMed. Prolonged fecal elimination of isoxazoline antiparasitic drugs in dogs and cats: is there a risk for nontarget species? Fluralaner and lotilaner were still detectable in feces even after the recommended treatment period had ended.

Using modeling to estimate what happens to insects that feed on or develop in the dung of treated animals, the researchers concluded that dung-feeding insects could be exposed to meaningful concentrations of isoxazolines, with fluralaner and lotilaner posing the greatest potential concern. Sarolaner’s shorter fecal half-life puts it at the lower end of the risk spectrum among these drugs, but the broader point is that these compounds don’t simply vanish after they’ve done their job inside the dog.12PubMed. Prolonged fecal elimination of isoxazoline antiparasitic drugs in dogs and cats: is there a risk for nontarget species?

Separate work has documented that pet dogs can transfer veterinary medicines to the wider environment. One study found fluralaner concentrations in swimming water that exceeded Dutch water quality standards, raising questions about potential effects on aquatic ecosystems.13PubMed. Pet dogs transfer veterinary medicines to the environment This research is still in its early stages, and no one is suggesting that dog owners stop using tick prevention. But as tens of millions of pets worldwide take these drugs monthly, the cumulative environmental footprint is something scientists are starting to take seriously. For the individual dog owner, the health benefit of protecting your pet from ticks and tick-borne diseases remains clear. At the population level, the environmental question is one to watch in the coming years.